Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity
暂无分享,去创建一个
[1] D. Ventrella,et al. Preliminary Assessment of the Mucosal Toxicity of Tea Tree (Melaleuca alternifolia) and Rosemary (Rosmarinus officinalis) Essential Oils on Novel Porcine Uterus Models , 2020, International journal of molecular sciences.
[2] R. Sadreyev,et al. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles , 2019, Front. Immunol..
[3] P. Bingley,et al. Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk. , 2019, JAMA.
[4] J. Ilonen,et al. Association of Cereal, Gluten, and Dietary Fiber Intake With Islet Autoimmunity and Type 1 Diabetes. , 2019, JAMA pediatrics.
[5] R. Leslie,et al. Looking back and looking forward: A brief history of research into type 1 diabetes , 2019, Diabetes/metabolism research and reviews.
[6] M. Rewers,et al. Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY) , 2019, Diabetes Care.
[7] D. Maahs,et al. Prevalence of celiac disease in 52,721 youth with T1DM: international comparison across three continents , 2018 .
[8] H. Yamanaka,et al. Genetic differences between type 1 diabetes with and without other autoimmune diseases , 2018, Diabetes/metabolism research and reviews.
[9] M. Redondo,et al. Genetics of type 1 diabetes , 2018, Pediatric diabetes.
[10] E. Bonifacio,et al. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children , 2018, PLoS medicine.
[11] Hae-sang Lee,et al. Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study , 2018, Annals of pediatric endocrinology & metabolism.
[12] M. Stumvoll,et al. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family , 2018, Front. Endocrinol..
[13] S. Virtanen,et al. Early Infant Diet and Islet Autoimmunity in the TEDDY Study , 2018, Diabetes Care.
[14] Å. Lernmark,et al. Co-occurrence of Type 1 Diabetes and Celiac Disease Autoimmunity , 2017, Pediatrics.
[15] A. Fasano,et al. Celiac Disease and Nonceliac Gluten Sensitivity: A Review , 2017, JAMA.
[16] S. Rich. Genetics and its potential to improve type 1 diabetes care , 2017, Current opinion in endocrinology, diabetes, and obesity.
[17] A. Fasano,et al. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model , 2017, Annals of the New York Academy of Sciences.
[18] D. Maahs,et al. Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents , 2017, Diabetes Care.
[19] V. Ferreira,et al. Properdin: a tightly regulated critical inflammatory modulator , 2016, Immunological reviews.
[20] A. Fasano,et al. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases , 2016, Tissue barriers.
[21] L. Dimeglio,et al. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose , 2016, Diabetes Care.
[22] Å. Lernmark. Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy , 2016, Pediatric diabetes.
[23] T. Orchard,et al. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes. , 2016, Journal of diabetes and its complications.
[24] P. Bingley,et al. The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes , 2015, Diabetologia.
[25] Xia Li,et al. The role for gut permeability in the pathogenesis of type 1 diabetes – a solid or leaky concept? , 2015, Pediatric diabetes.
[26] J. Noble. Immunogenetics of type 1 diabetes: A comprehensive review. , 2015, Journal of autoimmunity.
[27] H. Hakonarson,et al. Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases , 2015, Current Diabetes Reports.
[28] C. Wijmenga,et al. Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity , 2015, Diabetes Care.
[29] Å. Lernmark,et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association , 2015, Diabetes Care.
[30] L. Dimeglio,et al. Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report , 2015, Diabetes Care.
[31] Alessio Fasano,et al. The Role of Gluten in Celiac Disease and Type 1 Diabetes , 2015, Nutrients.
[32] C. Gutiérrez,et al. Haptoglobin genotype is associated with increased endothelial dysfunction serum markers in type 1 diabetes , 2015, European journal of clinical investigation.
[33] G. Ambler,et al. Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review , 2015, Pediatrics.
[34] J. Murray,et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. , 2015, Gastroenterology.
[35] Olli Simell,et al. HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study , 2015, The American Journal of Gastroenterology.
[36] Marian Rewers,et al. Daycare Attendance, Breastfeeding, and the Development of Type 1 Diabetes: The Diabetes Autoimmunity Study in the Young , 2015, BioMed research international.
[37] J. Ludvigsson,et al. Systematic review with meta‐analysis: associations between coeliac disease and type 1 diabetes , 2014, Alimentary pharmacology & therapeutics.
[38] P. Bingley,et al. Risk of pediatric celiac disease according to HLA haplotype and country. , 2014, The New England journal of medicine.
[39] Jasmin Divers,et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. , 2014, JAMA.
[40] E. Bonifacio,et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.
[41] R. Arsenescu,et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study , 2013, Alimentary pharmacology & therapeutics.
[42] R. Hamman,et al. Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2050 , 2012, Diabetes Care.
[43] M. Vardi,et al. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. , 2012, European journal of internal medicine.
[44] A. Fasano. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[45] S. Kupfer,et al. Pathophysiology of celiac disease. , 2012, Gastrointestinal endoscopy clinics of North America.
[46] A. Fasano. Zonulin, regulation of tight junctions, and autoimmune diseases , 2012, Annals of the New York Academy of Sciences.
[47] C. Beam,et al. Fall in C-Peptide During First 2 Years From Diagnosis , 2012, Diabetes.
[48] K. Giersiepen,et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[49] Sarah Edkins,et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease , 2011, Nature Genetics.
[50] Christiane Winkler,et al. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. , 2011, Journal of autoimmunity.
[51] P. Rutgeerts,et al. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis , 2011, Gut.
[52] A. Steck,et al. Stepwise or Linear Decrease in Penetrance of Type 1 Diabetes With Lower-Risk HLA Genotypes Over the Past 40 Years , 2011, Diabetes.
[53] K. Vehik,et al. The changing epidemiology of type 1 diabetes: why is it going through the roof? , 2011, Diabetes/metabolism research and reviews.
[54] A. Fasano. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. , 2011, Physiological reviews.
[55] M. Rewers,et al. An exploration of Glo‐3A antibody levels in children at increased risk for type 1 diabetes mellitus , 2009, Pediatric diabetes.
[56] A. Fasano,et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 , 2009, Proceedings of the National Academy of Sciences.
[57] R. Ferrell,et al. Haptoglobin Genotype and Renal Function Decline in Type 1 Diabetes , 2009, Diabetes.
[58] Jeroen Visser,et al. Tight Junctions, Intestinal Permeability, and Autoimmunity , 2009, Annals of the New York Academy of Sciences.
[59] Cisca Wijmenga,et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. , 2008, The New England journal of medicine.
[60] J. Neu,et al. The “Perfect Storm” for Type 1 Diabetes , 2008, Diabetes.
[61] Sefik Alkan,et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. , 2008, Gastroenterology.
[62] K. Vehik,et al. Trends in High-Risk HLA Susceptibility Genes Among Colorado Youth With Type 1 Diabetes , 2008, Diabetes Care.
[63] R. Ferrell,et al. Haptoglobin Genotype , 2008, Diabetes.
[64] G. Morahan,et al. The Rising Incidence of Type 1 Diabetes Is Accounted for by Cases With Lower-Risk Human Leukocyte Antigen Genotypes , 2008, Diabetes Care.
[65] G. Veres,et al. Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. , 2008, Clinical chemistry.
[66] A. Fasano,et al. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study , 2007, Alimentary pharmacology & therapeutics.
[67] J. Enghild,et al. A Unique Loop Extension in the Serine Protease Domain of Haptoglobin Is Essential for CD163 Recognition of the Haptoglobin-Hemoglobin Complex* , 2007, Journal of Biological Chemistry.
[68] Dario Iafusco,et al. Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives , 2006, Diabetes.
[69] E. Fries,et al. Haptoglobin, a hemoglobin-binding plasma protein, is present in bony fish and mammals but not in frog and chicken. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[70] Giuseppe Iacono,et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines , 2006, Scandinavian journal of gastroenterology.
[71] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[72] A. Fasano,et al. INHIBITION OF ZONULIN-MEDIATED INCREASED INTESTINAL PERMEABILITY BLOCKS PROGRESSION FROM PRE-CLINICAL AUTOIMMUNITY TO TYPE 1 DIABETES IN BB/WOR RATS: 211 , 2005 .
[73] G. Coppa,et al. EFFECT OF GLUTEN-CONTAINING DIET ON SERUM ZONULIN AND INTESTINAL PERMEABILITY IN TYPE 1 DIABETES CHILDREN AND THEIR RELATIVES: 209 , 2005 .
[74] B. Lie,et al. Celiac disease genetics: current concepts and practical applications. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[75] Ronald H. Zielke,et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[76] G. Rook,et al. Microbes, immunoregulation, and the gut , 2005, Gut.
[77] P. Bingley,et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes , 2004, The Lancet.
[78] Heather J Cordell,et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. , 2004, The Journal of clinical endocrinology and metabolism.
[79] R. Lorini,et al. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. , 2004, Diabetes care.
[80] J. Nataro,et al. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. , 2004, Advanced drug delivery reviews.
[81] E. Bonifacio,et al. Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. , 2004, Clinical immunology.
[82] P. Bingley,et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. , 2004, Diabetes.
[83] R. Fujinami,et al. Microorganisms and autoimmunity: making the barren field fertile? , 2003, Nature Reviews Microbiology.
[84] G. Coppa,et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. , 2002, Gastroenterology.
[85] J. Bach,et al. The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.
[86] J. Ilonen,et al. Intestinal Permeability to Mannitol and Lactulose in Children with Type 1 Diabetes with the HLA-DQB1*02 Allele , 2002, Autoimmunity.
[87] A. Fasano,et al. Human zonulin, a potential modulator of intestinal tight junctions. , 2000, Journal of cell science.
[88] A. Fasano,et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease , 2000, The Lancet.
[89] G. Law,et al. Early social mixing and childhood Type 1 diabetes mellitus: a case–control study in Yorkshire, UK , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[90] J. Delanghe,et al. Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.
[91] J. Todd,et al. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.
[92] B Touchstone,et al. Covalent structure of human haptoglobin: a serine protease homolog. , 1980, Proceedings of the National Academy of Sciences of the United States of America.